-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Amylyx Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q3 2024.
- Amylyx Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$75.7M, a 504% decline year-over-year.
- Amylyx Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$272M, a 3423% decline year-over-year.
- Amylyx Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was $38.8M.
- Amylyx Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$201M, a 143% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)